IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
89 hedge funds and large institutions have $120M invested in Insight Molecular Diagnostics Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 17 closing their positions.
Holders
89
Holders Change
-6
Holders Change %
-6.32%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
28
Reduced
31
Closed
17
Calls
$626K
Puts
$88K
Net Calls
+$538K
Net Calls Change
-$564K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$7.58M |
2 |
2
BlackRock
New York
|
$10.8M |
3 |
DC
3
Defender Capital
Charlotte,
North Carolina
|
$4.81M |
4 |
GCP
4
GSA Capital Partners
London,
United Kingdom
|
$547K |
5 |
5
Morgan Stanley
New York
|
$534K |